| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00087 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |